Cargando…
AQP4 autoantibody assay performance in clinical laboratory service
OBJECTIVE: To compare performance of contemporary aquaporin-4–immunoglobulin (Ig) G assays in clinical service. METHODS: Sera from neurologic patients (4 groups) and controls were tested initially by service ELISA (recombinant human aquaporin-4, M1 isoform) and then by cell-based fluorescence assays...
Autores principales: | Fryer, J.P., Lennon, V.A., Pittock, S.J., Jenkins, S.M., Fallier-Becker, P., Clardy, S.L., Horta, E., Jedynak, E.A., Lucchinetti, C.F., Shuster, E.A., Weinshenker, B.G., Wingerchuk, D.M., McKeon, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202686/ https://www.ncbi.nlm.nih.gov/pubmed/25340055 http://dx.doi.org/10.1212/NXI.0000000000000011 |
Ejemplares similares
-
Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians
por: Majed, Masoud, et al.
Publicado: (2016) -
NMO-IgG: A Specific Biomarker for Neuromyelitis Optica
por: Weinshenker, Brian G., et al.
Publicado: (2006) -
Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD
por: Jitprapaikulsan, Jiraporn, et al.
Publicado: (2020) -
Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity
por: Zekeridou, Anastasia, et al.
Publicado: (2019) -
Diagnostic value of aquaporin-4-IgG live cell based assay in
neuromyelitis optica spectrum disorders
por: Redenbaugh, Vyanka, et al.
Publicado: (2021)